CHMA issued CRL. TRVN Phase 2b data to be presented May 21. RGLS primary endpoint data due later this quarter.
Updates to the Company Pipeline Database for April 15, 2016 are as follows. Refer to the FDA Calendar for upcoming catalysts: Ticker Price Drug Indication Stage Summary CHMA 3.30 Mycapssa Acromegaly CRL CRL April 15 2016 RGLS 7.23 RG-101 with multiple approved DAAs HCV Phase 2 Additional Phase 2 interim data released April 2016. Primary endpoint data due late […]